Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Accounts Payables (2020 - 2023)

Historic Accounts Payables for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $3.3 million.

  • Terns Pharmaceuticals' Accounts Payables rose 5878.7% to $3.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $3.3 million, marking a year-over-year increase of 5878.7%. This contributed to the annual value of $1.6 million for FY2022, which is 2262.46% down from last year.
  • Terns Pharmaceuticals' Accounts Payables amounted to $3.3 million in Q3 2023, which was up 5878.7% from $5.5 million recorded in Q2 2023.
  • Terns Pharmaceuticals' Accounts Payables' 5-year high stood at $5.5 million during Q2 2023, with a 5-year trough of $935000.0 in Q4 2020.
  • Over the past 4 years, Terns Pharmaceuticals' median Accounts Payables value was $1.9 million (recorded in 2021), while the average stood at $2.4 million.
  • In the last 5 years, Terns Pharmaceuticals' Accounts Payables crashed by 6051.76% in 2022 and then surged by 46906.47% in 2023.
  • Over the past 4 years, Terns Pharmaceuticals' Accounts Payables (Quarter) stood at $935000.0 in 2020, then surged by 127.38% to $2.1 million in 2021, then dropped by 22.62% to $1.6 million in 2022, then soared by 102.13% to $3.3 million in 2023.
  • Its Accounts Payables was $3.3 million in Q3 2023, compared to $5.5 million in Q2 2023 and $2.7 million in Q1 2023.